What is iCliniq Tes - Hemophilia AI Assistant?
iCliniq Tes is your AI-powered hemophilia companion, crafted by expert physicians to help you track symptoms, prevent complications, and stay treatment-aware. Get real-time support and personalized insights for smarter care every step of the way.
Problem
Users with hemophilia track symptoms manually and lack real-time medical support, leading to delayed interventions and increased risk of complications.
Solution
AI-powered healthcare tool enabling users to track symptoms, receive personalized insights, and access real-time medical guidance from expert physicians, e.g., logging bleeds or treatment schedules for proactive care.
Customers
Hemophilia patients, caregivers managing chronic symptoms, and physicians seeking data-driven patient monitoring.
Unique Features
Expert physician-crafted AI algorithms, personalized complication prevention alerts, and treatment-awareness features tailored to hemophilia subtypes.
User Comments
Simplifies symptom tracking
Provides actionable medical insights
Reduces anxiety with real-time support
Enhances treatment adherence
Trusted for physician-backed accuracy
Traction
Launched in 2023 with features updated monthly, developed by iCliniq’s team of 200+ doctors; parent company serves 5M+ patients annually.
Market Size
The global hemophilia treatment market was valued at $13.4 billion in 2023 (Grand View Research).
